To add to this, we are now in phase weighted towards commercialisation compared to R&D (of course R&D for pipeline products are ongoing), but now is really a time to drive continued uptake of products into global markets.
John Van Der Wielen was one of the earliest change to the Board as Chairman, and has already helped us make significant commercial inroads in the 9 months he's been onboard.
Dr Fiona Wood AO will also help us with commercialisation given her global commercialisation success with spray on skin / Avita Medical and her stature in the health professional and beyond.
Dr Ravi I. Thadhani would be helpful for us given our upcoming expected submission for Remplir and his FDA and US regulatory pathway experience.
Hon Kim Beazley AC will assist us with US commercialisation which is our main growth market given his US affiliations through his previous U.S. ambassadorship.
OCC Trading, page-1636
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.010(2.82%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $21.15K | 58.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73647 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 102800 | 2 |
View Market Depth
| Last trade - 12.24pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |